|
MILGa-01: A first-in-human study assessing the safety and tolerability of chMIL-38 in metastatic prostate, bladder, and pancreatic cancers. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Minomic |
|
|
Consulting or Advisory Role - Minomic |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Minomic |
Research Funding - Minomic |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Minomic |
Research Funding - Minomic (Inst) |